(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.38%) $966.30
(-0.36%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
Quarter results today
(bmo 2024-05-03)
Expected move: +/- 2.44%
1.15% £ 639.29
Live Chart Being Loaded With Signals
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies...
Stats | |
---|---|
Volumen de hoy | 26 918.00 |
Volumen promedio | 60 636.00 |
Capitalización de mercado | 241.06M |
EPS | £0 ( 2024-04-30 ) |
Last Dividend | £14.20 ( 2023-07-27 ) |
Next Dividend | £0 ( N/A ) |
P/E | 37.61 |
ATR14 | £3.22 (0.50%) |
Volumen Correlación
International Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
International Correlación - Moneda/Commodity
International Finanzas
Annual | 2023 |
Ingresos: | £8.49M |
Beneficio Bruto: | £8.49M (100.00 %) |
EPS: | £0.170 |
FY | 2023 |
Ingresos: | £8.49M |
Beneficio Bruto: | £8.49M (100.00 %) |
EPS: | £0.170 |
FY | 2022 |
Ingresos: | £-21.10M |
Beneficio Bruto: | £-21.10M (100.00 %) |
EPS: | £-0.550 |
FY | 2021 |
Ingresos: | £29.12M |
Beneficio Bruto: | £0.00 (0.00 %) |
EPS: | £0.725 |
Financial Reports:
No articles found.
International Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£15.70 (N/A) |
£14.00 (N/A) |
£0 (N/A) |
£0 (N/A) |
£14.20 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £1.000 | 1995-11-13 |
Last Dividend | £14.20 | 2023-07-27 |
Next Dividend | £0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 15 | -- |
Total Paid Out | £191.80 | -- |
Avg. Dividend % Per Year | 2.11% | -- |
Score | 4.55 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.50 | |
Div. Directional Score | 8.52 | -- |
Year | Amount | Yield |
---|---|---|
1995 | £0 | 0.00% |
1996 | £0 | 0.00% |
1997 | £0 | 0.00% |
1998 | £0 | 0.00% |
1999 | £0 | 0.00% |
2000 | £0 | 0.00% |
2001 | £0 | 0.00% |
2002 | £0 | 0.00% |
2003 | £0 | 0.00% |
2004 | £0 | 0.00% |
2005 | £0 | 0.00% |
2006 | £0 | 0.00% |
2007 | £0 | 0.00% |
2008 | £0 | 0.00% |
2009 | £0 | 0.00% |
2010 | £0 | 0.00% |
2011 | £0 | 0.00% |
2012 | £0 | 0.00% |
2013 | £0 | 0.00% |
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £41.00 | 7.36% |
2019 | £26.40 | 4.63% |
2020 | £26.60 | 4.28% |
2021 | £29.90 | 3.70% |
2022 | £29.70 | 4.04% |
2023 | £14.20 | 1.97% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
WTB.L | Dividend Knight | 2023-05-25 | Annually | 33 | 0.87% | |
NTV.L | Dividend Knight | 2023-07-20 | Semi-Annually | 25 | 4.03% | |
EMG.L | Dividend King | 2023-08-10 | Semi-Annually | 31 | 3.60% | |
SPT.L | Dividend Knight | 2023-08-10 | Semi-Annually | 32 | 1.51% | |
JD.L | Dividend Knight | 2023-12-07 | Annually | 28 | 0.21% | |
BUT.L | Dividend King | 2023-08-03 | Quarterly | 49 | 1.28% | |
PNL.L | Dividend Knight | 2023-08-24 | Quarterly | 41 | 0.75% | |
FSFL.L | Dividend Knight | 2023-07-20 | Quarterly | 11 | 3.85% | |
AERI.L | Dividend Junior | 2023-08-17 | Quarterly | 6 | 2.80% | |
THRG.L | Dividend Knight | 2023-08-03 | Semi-Annually | 52 | 1.02% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.651 | 1.500 | 10.00 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0223 | 1.200 | 9.26 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0241 | 1.500 | -0.844 | -1.265 | [0.1 - 1] |
payoutRatioTTM | 1.674 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 19.01 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 19.01 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0.213 | -1.500 | 6.45 | -9.67 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.676 | 2.00 | 9.77 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.676 | 2.00 | 9.66 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.240 | -1.500 | 9.04 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 1.000 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.629 | 1.000 | 10.00 | 10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.420 | 1.000 | 8.78 | 8.78 | [0.2 - 2] |
assetTurnoverTTM | 0.0343 | 0.800 | -3.10 | -2.48 | [0.5 - 2] |
Total Score | 10.54 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 37.45 | 1.000 | 6.32 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0241 | 2.50 | -0.542 | -1.265 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.676 | 2.00 | 9.77 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.45 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.676 | 2.00 | 9.77 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.674 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 28.61 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 2.61 | 1.000 | 10.00 | 0 | [0.1 - 0.5] |
Total Score | 6.50 |
International
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico